Serif Biomedicines has emerged from stealth mode to continue developing “modified DNA,” a new class of therapeutics designed ...

Following Flagship's origination of generative protein and mRNA platforms, Serif is pioneering Modified DNA medicines to program the foundational information layer of biology Serif to present data at ...

With a few chemical tweaks and some dutiful protein partners, a new biotech from Flagship Pioneering thinks it has cracked ...

Scientists have developed a way to turn the body's own immune cells into cancer-fighting agents—without removing them from ...

Flagship Pioneering launched Serif Biomedicines to create modified DNA drugs, taking the best features of mRNA and gene ...

Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...

The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...

CareDx’s plans to acquire Naveris follow the divestment of its lab products business earlier this month, reporting flat ...

Serif Biomedicines has emerged from stealth with $50 million in start-up funding. The new firm is developing what it calls ...

In a new study of women in post-menopause, white women with higher genetic risk of obesity regained weight about two times ...

The DNA synthesis market offers significant growth opportunities driven by tailored therapies, DNA-based research, and diagnostics. Key market prospects include advancements in enzymatic synthesis, ...